Recombinant E. coli Strain for Phenylethanoid Biosynthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing phenylethanoids such as 2-phenylethanol, tyrosol, and hydroxytyrosol are inefficient and costly due to limitations in yeast and Escherichia coli metabolic pathways, leading to low yields and high production costs.
Innovation Solution
A recombinant Escherichia coli strain is developed that co-expresses four enzymes: L-amino acid oxidase, α-keto acid decarboxylase, alcohol dehydrogenase, and an enzyme capable of reducing NAD(P) to NAD(P)H, allowing for the whole-cell catalytic transformation of L-phenylalanine, L-tyrosine, and L-dopa into 2-phenylethanol, tyrosol, and hydroxytyrosol.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If yeast is used for transforming L-phenylalanine to 2-phenylethanol, then the transformation can be achieved, but the yield is low and production cost is high due to slow growth and consumption of substrate
Solution Approach 1:
The patent changes the biological system parameters by switching from yeast to Escherichia coli as the host organism, which has faster growth rate and different metabolic characteristics. This parameter change resolves the contradiction by achieving both high transformation efficiency and low substrate consumption through the bacterial metabolic pathway
2Productivity
If Escherichia coli over-expresses phenylpyruvate decarboxylase and alcohol dehydrogenase, then 2-phenylethanol production is enhanced, but the metabolic balance is disturbed and yield is limited
Solution Approach 1:
The patent segments the metabolic pathway into distinct enzymatic steps with separate gene expressions. By dividing the transformation pathway into manageable segments (aromatic amino acid transaminase, phenylpyruvate decarboxylase, alcohol dehydrogenase), each enzyme can be optimized independently while maintaining overall metabolic balance
Solution Approach 2:
The patent changes the expression levels and ratios of different enzymes in the pathway. By adjusting the relative expression parameters of each enzyme, the metabolic flux is optimized to maintain balance while maximizing product yield, resolving the contradiction between productivity and metabolic stability
3Productivity
If multiple enzymes are co-expressed in Escherichia coli for whole cell transformation, then the transformation efficiency is improved, but the system complexity and production cost increase
Solution Approach 1:
The patent merges multiple enzyme functions into a single Escherichia coli host cell, creating an integrated whole-cell biocatalyst. This combining approach achieves high transformation efficiency while simplifying the overall system by eliminating the need for separate enzyme purification and reaction systems
Solution Approach 2:
The patent creates a universal Escherichia coli strain that can perform multiple functions: substrate uptake, enzymatic transformation, and product secretion. This multi-functional strain resolves the contradiction by achieving high efficiency through integrated operations while maintaining relatively simple system architecture
4Manufacturing precision
If plant extraction methods are used to produce phenylethanoids, then high purity products can be obtained, but the production cost is high due to resource limitations
Solution Approach 1:
The patent replaces the mechanical extraction process with a biological transformation system. Instead of extracting compounds from plant materials through physical and chemical processes, the system uses engineered Escherichia coli to biosynthesize phenylethanoids directly from L-phenylalanine, achieving both high purity and cost-effectiveness
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The strain achieves a cost-effective and efficient production of phenylethanoids with improved yields and simplified processes, demonstrating good industrial application prospects.
Implementation Method 1
L-amino acid oxidase from Proteus mirabilis ATCC 29906 or Cosenzaea myxofaciens ATCC 19692
Implementation Method 2
α-keto acid decarboxylase from Proteus mirabilis ATCC 29906 or Lactococcus lactis ATCC 19435
Implementation Method 3
alcohol dehydrogenase from Escherichia coli BL21(DE3)
Implementation Method 4
an enzyme capable of reducing NAD(P) to NAD(P)H
Data Source
AI summary
The present disclosure discloses a genetically engineered strain, belonging to the technical field of bioengineering. L-amino acid oxidase genes, α-keto acid decarboxylase genes, alcohol dehydrogenase genes, and enzyme genes capable of reducing NAD(P) to NAD(P)H are introduced into the genetically engineered strain of the present disclosure. The present disclosure further discloses a construction method and application of a recombinant Escherichia coli genetically engineered strain. When being applied to the biosynthesis of phenylethanoids, the method of the present disclosure has the characteristics of simple operation, low cost, and high synthesis efficiency and optical purity of the product, and has good industrialization prospects.